MyOme Presents New Data at ASCO 2022 on Cross-ancestry Polygenic Risk Score for Breast Cancer

Study highlights potential of Polygenic Risk Scores (PRS) to improve breast cancer risk assessment in women across multiple ancestries MENLO PARK, Calif., June 1, 2022 /PRNewswire/ -- MyOme, a clinical whole genome platform analysis company, today announced new data on a cross ancestry...

Click to view original post